Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
Julphar
Healthtrust
McKesson
US Department of Justice

Generated: March 19, 2019

DrugPatentWatch Database Preview

SALAGEN Drug Profile

« Back to Dashboard

Which patents cover Salagen, and when can generic versions of Salagen launch?

Salagen is a drug marketed by Eisai Inc and is included in one NDA.

The generic ingredient in SALAGEN is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.

Drug patent expirations by year for SALAGEN
Pharmacology for SALAGEN
Synonyms for SALAGEN
(+)-Pilocarpine
(3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone
(3S-cis)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone
(3S,4R)-3-Ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydrofuran-2(3H)-one
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]oxolan-2-one
(3S,4R)-3-ethyl-4-[(1-methylimidazol-5-yl)methyl]-3,4,5-trihydrofuran-2-one
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one
(3S,4R)-3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone
01MI4Q9DI3
092P137
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, (3S-cis)-
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, (3S,4R)-
2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)-
91484-73-0
92-13-7
AB00053525_28
AB00053525_29
AB00053525-27
AC1L1LEF
AI3-50523
AK116461
Akarpine
AKOS016010311
AN-42585
AX8148055
BDBM50008072
beta-Pilocarpine hydrochloride
BIDD:GT0217
BPBio1_000548
BRD-K85090592-008-05-2
BRD-K85090592-008-15-1
BSPBio_000498
BSPBio_002191
C07474
CAS-92-13-7
CCG-205031
CHEBI:8207
CHEMBL550
D00525
DB01085
DivK1c_000358
DSSTox_CID_1162
DSSTox_GSID_21162
DSSTox_RID_75984
DTXSID1021162
EINECS 202-128-4
Epicar
GTPL305
HMS2089K17
HSDB 3163
IDI1_000358
Imidazole-5-butyric acid, alpha-ethyl-beta-(hydroxymethyl)-1-methyl-, gamma-lactone
Isoptocarpine
KB-207616
KBio1_000358
KBio2_001587
KBio2_004155
KBio2_006723
KBio3_001691
KBioGR_000956
KBioSS_001587
Lopac0_000950
Lopac0_000960
LS-187208
LS-7661
MCULE-2634151840
Mi-Pilo
Minims Pilocarpine
Miocarpine
NCGC00023339-03
NCGC00023339-06
NCGC00023339-07
NCGC00023339-08
NCGC00023339-09
NCGC00023339-10
NCGC00023339-11
NCGC00023339-12
NCGC00023339-13
NCGC00023339-14
NCGC00023339-16
NCI60_004403
NINDS_000358
NSC5746
Ocu-Carpine
Ocusert
Ocusert P 20
Ocusert pilo
Ocusert pilo-20
Ocusert pilo-20 (TN)
Ocusert Pilo-40
P.V. Carpine Liquifilm
Pilagan
Pilocarpin
pilocarpine
Pilocarpine (JAN/USP)
Pilocarpine [USAN:BAN:JAN]
Pilocarpine [USP:BAN:JAN]
Pilocarpine chloride
Pilocarpine monohydrochloride
Pilocarpine Mononitrate, (3S-cis)-Isomer
Pilocarpine nitrate salt
Pilocarpine-d3 HCl (deuterated)
Pilocarpine, Monohydrochloride, (3S-cis)-Isomer
Pilocarpol
Pilokarpin
Pilokarpol
Piloptic-1
Piloptic-1/2
Piloptic-2
Piloptic-3
Piloptic-4
Piloptic-6
Pilostat
Prestwick0_000449
Prestwick1_000449
Prestwick2_000449
Prestwick3_000449
QCHFTSOMWOSFHM-WPRPVWTQSA-N
SBB012409
SBI-0050924.P004
SCHEMBL15146
SDCCGMLS-0003164.P005
SPBio_001287
SPBio_002437
Spectrum_001107
Spectrum2_001284
Spectrum3_000546
Spectrum4_000478
Spectrum5_001379
Spersacarpine
SR-01000075339-11
ST069319
Syncarpine
Tocris-0694
Tox21_110887
Tox21_110887_1
UNII-01MI4Q9DI3
ZINC75008

US Patents and Regulatory Information for SALAGEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc SALAGEN pilocarpine hydrochloride TABLET;ORAL 020237-001 Mar 22, 1994 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Eisai Inc SALAGEN pilocarpine hydrochloride TABLET;ORAL 020237-002 Apr 18, 2003 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Deloitte
Covington
Julphar
Mallinckrodt
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.